Association of serum amylase with insufficient insulin action in Type I and Type II Diabetes Mellitus and Metabolic syndrome
Journal Title: International Journal of Clinical Biochemistry and Research - Year 2016, Vol 3, Issue 4
Abstract
Background: Metabolic syndrome (MetS) and Diabetes mellitus (type I and type II) are emerging as epidemics among non communicable diseases. A lot of research has been done on hyperglycemia in Diabetes mellitus and Metabolic syndrome, but very few studies on pancreatic exocrine function have been conducted in these conditions. Therefore, the present study is an attempt to link endocrine and exocrine parts of the pancreas by investigating the association of serum amylase with insufficient insulin action in clinical settings. Objectives: To estimate and compare serum amylase and insulin levels in Metabolic syndrome and in type I Diabetes mellitus and type II Diabetes mellitus Materials and Methods: The subjects included in this study were divided into 3 groups. Group I consisted of 30 Diabetes mellitus Type I patients aged ≤ 25 yrs. Group II consisted of 30 patients of Diabetes mellitus Type II aged ≥ 40 yrs and Group III consisted of 30 Metabolic syndrome patients aged ≥ 40 yrs. Serum insulin, Serum amylase, Fasting blood sugar (FBS) and lipid profile were measured using autoanalyser. Statistical package for social science software version 15 was used for statistical analysis. Results: Serum amylase was significantly less in DM Type I (40.53±16.58) compared to both DM Type II (75.13±44.81) and Metabolic syndrome (58.77±17.45). The insulin levels were lowest in DM Type I compared to both DM Type II and MetS. In DM Type I, there was a positive correlation between insulin & amylase levels. In DM Type II and MetS there was a positive correlation between insulin & amylase levels at low insulin levels of ≤10 µIU/ ml and negative correlation with insulin résistance i.e. the serum amylase was lower with higher insulin résistance than with moderate insulin resistance. Conclusion: Our results suggest a significant association between serum amylase levels and insufficient insulin action either due to inadequate insulin secretion and/or insulin resistance in Type I DM, Type II DM and MetS. This indicates a possible exocrineendocrine relationship in these clinical conditions. Low serum amylase is associated with decreased basal insulin levels and insulin secretion, as well as high insulin resistance than with moderate resistance. Low serum amylase suggests exocrine pancreatic insufficiency and if pancreatic amylase replacement therapy is given to these patients it may improve the nutritional status and also analysis of serum amylase could provide valuable information regarding prognosis of the illness.
Authors and Affiliations
Chandana G, Nina M. Veigas, Raghavendra DS
Keywords
Related Articles
- EP ID EP243057
- DOI -
- Views 109
- Downloads 0
Prevalence of childhood obesity and its determinants among rural children of B G Nagara
Introduction India is witnessing under nutrition as one of the major public health problem however there exists a significant magnitude of overweight and obesity among children and adolescent Childhood obesity has emerge...
Evaluation of coagulation profile in patients suffering with type-2 diabetes mellitus: A hospital based prospective study
Introduction: T2DM and its complications develop due to uncontrolled plasma glucose levels for long time. Long term hyperglycemia will cause glycation of various tissue proteins. It also affects the coagulation process a...
MDM2 promoter polymorphism (rs2279744) and serum estrogen level are associated with increased risk of epithelial ovarian cancer: A case-control study
Introduction Epithelial ovarian cancer EOC is most common malignancy affecting Indian women One of the transcriptional targets of p53 is human homolog of Murine Double Minute 2 Oncogene MDM2 which is a crucial negative r...
Study of malondialdehyde and estimation of blood glucose levels in patients with diabetes mellitus with cataract
Increased oxidative stress may contribute to development of complications in diabetes may result from over production of precursors to reactive oxygen radicals and/ or decreased efficiency of inhibitory scavenger systems...
Is Placental Growth Factor an angiogenic marker in type 2 diabetes mellitus?
Introduction: Type 2 diabetes mellitus (T2DM) known by vascular complications due to abnormal angiogenesis leading to micro and macro vascular complications. PlGF a close homolog of VEGF, shares receptors with VEGF, and...